OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+49.06%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$459M
AUM Growth
+$459M
(+22%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-25.1%
Top 10 Holdings %
Top 10 Hldgs %
57.01%
Holding
59
New
13
Increased
16
Reduced
16
Closed
7
Top Buys
| 1 |
Lyell Immunopharma
LYEL
|
$7.48M |
| 2 |
Compass Therapeutics
CMPX
|
$6.28M |
| 3 |
Ocular Therapeutix
OCUL
|
$5.31M |
| 4 |
Applied Therapeutics
APLT
|
$4.61M |
| 5 |
Intellia Therapeutics
NTLA
|
$4.29M |
Top Sells
| 1 |
Jasper Therapeutics
JSPR
|
$104M |
| 2 |
SLRN
ACELYRIN
SLRN
|
$17.3M |
| 3 |
IDEAYA Biosciences
IDYA
|
$11.1M |
| 4 |
Biohaven
BHVN
|
$8.56M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
$6.33M |
Sector Composition
| 1 | Healthcare | 99.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Repare Therapeutics
RPTX
$71.7M
| $318K | 0.07% | +67,561 | New | +$318K |
|
|
52
Arcutis Biotherapeutics
ARQT
$1.86B
| – | – | -1,960,000 | Closed | -$6.33M |
|
|
53
Biohaven
BHVN
$1.63B
| – | – | -200,000 | Closed | -$8.56M |
|
|
54
IDEAYA Biosciences
IDYA
$2.15B
| – | – | -311,500 | Closed | -$11.1M |
|
55
KalVista Pharmaceuticals
KALV
$678M
| – | – | -150,000 | Closed | -$1.84M |
|
56
Kiniksa Pharmaceuticals
KNSA
$2.48B
| – | – | -37,500 | Closed | -$640K |
|
57
Sutro Biopharma
STRO
$72.7M
| – | – | -301,491 | Closed | -$1.29M |
|
|
MRNS
58
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – | -563,500 | Closed | -$6.13M |
|